Variant report
Variant | rs56363459 |
---|---|
Chromosome Location | chr2:86054301-86054302 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:86029800-86054400 | Weak transcription | Spleen | Spleen |
2 | chr2:86039800-86074800 | Weak transcription | Aorta | Aorta |
3 | chr2:86042200-86054800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr2:86045600-86054400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr2:86049800-86054800 | Weak transcription | Lung | lung |
6 | chr2:86051400-86054400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
7 | chr2:86051800-86054800 | Weak transcription | Primary monocytes fromperipheralblood | blood |
8 | chr2:86054200-86054400 | Active TSS | Brain Angular Gyrus | brain |
9 | chr2:86054200-86054400 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr2:86054200-86054400 | Active TSS | Brain Inferior Temporal Lobe | brain |
11 | chr2:86054200-86054600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr2:86054200-86054600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
13 | chr2:86054200-86054600 | Flanking Active TSS | Brain Dorsolateral Prefrontal Cortex | brain |
14 | chr2:86054200-86054600 | Enhancers | Brain Substantia Nigra | brain |
15 | chr2:86054200-86054600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
16 | chr2:86054200-86054800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr2:86054200-86054800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
18 | chr2:86054200-86055000 | Enhancers | H9 Cell Line | embryonic stem cell |
19 | chr2:86054200-86055400 | Enhancers | Fetal Muscle Leg | muscle |
20 | chr2:86054200-86055600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
21 | chr2:86054200-86055800 | Enhancers | Fetal Thymus | thymus |